(-)-demecolcine increases expression EXP 6480464 Demecolcine results in increased expression of GPNMB mRNA CTD PMID:23649840 (S)-nicotine increases expression EXP 6480464 Nicotine results in increased expression of GPNMB mRNA CTD PMID:23825647 1,1-dichloroethene increases expression ISO RGD:733525 6480464 vinylidene chloride results in increased expression of GPNMB mRNA CTD PMID:26682919 1,2-dimethylhydrazine increases expression ISO RGD:71008 6480464 1, 2-Dimethylhydrazine results in increased expression of GPNMB mRNA CTD PMID:27840820 1-(3-(trifluoromethyl)phenyl)piperazine increases expression ISO RGD:71008 6480464 1-(3-trifluoromethylphenyl)piperazine results in increased expression of GPNMB mRNA CTD PMID:26821219 1-[(4-chlorophenyl)-phenylmethyl]-4-methylpiperazine increases expression ISO RGD:71008 6480464 chlorcyclizine results in increased expression of GPNMB mRNA CTD PMID:21058326 1-benzylpiperazine increases expression ISO RGD:71008 6480464 N-benzylpiperazine results in increased expression of GPNMB mRNA CTD PMID:26821219 1-chloro-2,4-dinitrobenzene increases expression EXP 6480464 Dinitrochlorobenzene results in increased expression of GPNMB mRNA CTD PMID:16314067 1-naphthyl isothiocyanate increases expression ISO RGD:71008 6480464 1-Naphthylisothiocyanate results in increased expression of GPNMB mRNA CTD PMID:25380136 , PMID:30723492 17alpha-ethynylestradiol affects expression ISO RGD:733525 6480464 Ethinyl Estradiol affects the expression of GPNMB mRNA CTD PMID:17555576 17alpha-ethynylestradiol increases expression ISO RGD:71008 6480464 Ethinyl Estradiol results in increased expression of GPNMB mRNA CTD PMID:17351261 17beta-estradiol multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GPNMB mRNA more ... CTD PMID:19619570 more ... 17beta-estradiol decreases expression EXP 6480464 Estradiol results in decreased expression of GPNMB mRNA CTD PMID:19619570 , PMID:21185374 2,3,7,8-tetrachlorodibenzodioxine multiple interactions EXP 6480464 [Estradiol co-treated with Tetrachlorodibenzodioxin] results in decreased expression of GPNMB mRNA CTD PMID:19619570 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:733525 6480464 Tetrachlorodibenzodioxin results in increased expression of GPNMB mRNA CTD PMID:26290441 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:733525 6480464 Tetrachlorodibenzodioxin affects the expression of GPNMB mRNA CTD PMID:21570461 , PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:71008 6480464 Tetrachlorodibenzodioxin results in increased expression of GPNMB mRNA CTD PMID:21215274 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of GPNMB mRNA CTD PMID:19619570 2,4-diaminotoluene increases expression ISO RGD:733525 6480464 2, 4-diaminotoluene results in increased expression of GPNMB mRNA CTD PMID:20713471 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:71008 6480464 3 more ... CTD PMID:23196670 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GPNMB mRNA CTD PMID:28628672 3-methylcholanthrene increases expression ISO RGD:733525 6480464 Methylcholanthrene results in increased expression of GPNMB mRNA CTD PMID:20713471 4,4'-diaminodiphenylmethane increases expression ISO RGD:71008 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GPNMB mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO RGD:733525 6480464 4, 4'-diaminodiphenylmethane results in increased expression of GPNMB mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GPNMB mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO RGD:733525 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of GPNMB mRNA CTD PMID:30951980 5-azacytidine decreases expression EXP 6480464 Azacitidine results in decreased expression of GPNMB mRNA CTD PMID:20823114 6-propyl-2-thiouracil increases expression ISO RGD:71008 6480464 Propylthiouracil results in increased expression of GPNMB mRNA CTD PMID:24780913 acrylamide increases expression ISO RGD:71008 6480464 Acrylamide results in increased expression of GPNMB mRNA CTD PMID:28959563 aflatoxin B1 decreases methylation EXP 6480464 Aflatoxin B1 results in decreased methylation of GPNMB exon CTD PMID:30157460 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of GPNMB mRNA CTD PMID:16249480 ammonium chloride affects expression ISO RGD:71008 6480464 Ammonium Chloride affects the expression of GPNMB mRNA CTD PMID:16483693 amphetamine increases expression ISO RGD:71008 6480464 Amphetamine results in increased expression of GPNMB mRNA CTD PMID:30779732 arsane increases expression ISO RGD:71008 6480464 Arsenic results in increased expression of GPNMB mRNA CTD PMID:18315880 arsane affects expression ISO RGD:71008 6480464 Arsenic affects the expression of GPNMB mRNA CTD PMID:18315880 arsenic atom affects expression ISO RGD:71008 6480464 Arsenic affects the expression of GPNMB mRNA CTD PMID:18315880 arsenic atom increases expression ISO RGD:71008 6480464 Arsenic results in increased expression of GPNMB mRNA CTD PMID:18315880 arsenous acid increases expression EXP 6480464 Arsenic Trioxide results in increased expression of GPNMB mRNA CTD PMID:26705709 , PMID:27829220 avobenzone increases expression EXP 6480464 avobenzone results in increased expression of GPNMB mRNA CTD PMID:31016361 benzo[a]pyrene decreases expression ISO RGD:733525 6480464 Benzo(a)pyrene results in decreased expression of GPNMB mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:733525 6480464 Benzo(a)pyrene results in increased expression of GPNMB mRNA CTD PMID:22228805 , PMID:23735875 benzo[a]pyrene multiple interactions ISO RGD:733525 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of GPNMB mRNA] CTD PMID:22228805 bicalutamide increases expression EXP 6480464 bicalutamide results in increased expression of GPNMB mRNA CTD PMID:15638997 bisphenol A increases expression ISO RGD:733525 6480464 bisphenol A results in increased expression of GPNMB mRNA CTD PMID:26063408 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of GPNMB mRNA CTD PMID:27685785 , PMID:29275510 bisphenol A decreases expression ISO RGD:733525 6480464 bisphenol A results in decreased expression of GPNMB mRNA CTD PMID:25594700 bisphenol A affects expression ISO RGD:71008 6480464 bisphenol A affects the expression of GPNMB mRNA CTD PMID:25181051 bucladesine multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GPNMB mRNA CTD PMID:20823114 cadmium dichloride affects expression ISO RGD:733525 6480464 Cadmium Chloride affects the expression of GPNMB mRNA CTD PMID:18974090 cadmium dichloride affects expression EXP 6480464 Cadmium Chloride affects the expression of GPNMB mRNA CTD PMID:25596134 cadmium dichloride increases expression ISO RGD:71008 6480464 Cadmium Chloride results in increased expression of GPNMB mRNA CTD PMID:25993096 cadmium sulfate multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPNMB mRNA CTD PMID:18654764 carbon nanotube increases expression ISO RGD:71008 6480464 Nanotubes, Carbon results in increased expression of GPNMB mRNA CTD PMID:24911292 carbon nanotube increases expression ISO RGD:733525 6480464 Nanotubes, Carbon analog results in increased expression of GPNMB mRNA, Nanotubes, Carbon results in increased expression of GPNMB mRNA CTD PMID:25554681 carvedilol decreases expression ISO RGD:71008 6480464 carvedilol results in decreased expression of GPNMB protein CTD PMID:20403466 cefaloridine increases expression ISO RGD:71008 6480464 Cephaloridine results in increased expression of GPNMB mRNA CTD PMID:18500788 chloroacetaldehyde affects expression EXP 6480464 chloroacetaldehyde affects the expression of GPNMB mRNA CTD PMID:25596134 chloroquine increases expression ISO RGD:71008 6480464 Chloroquine results in increased expression of GPNMB mRNA CTD PMID:19393257 chlorpromazine increases expression ISO RGD:71008 6480464 Chlorpromazine results in increased expression of GPNMB mRNA CTD PMID:25596134 choline multiple interactions ISO RGD:733525 6480464 [Dietary Fats co-treated with Choline deficiency] results in increased expression of GPNMB mRNA more ... CTD PMID:20938992 , PMID:29246445 chromium(6+) affects expression ISO RGD:733525 6480464 chromium hexavalent ion affects the expression of GPNMB mRNA CTD PMID:28472532 cidofovir anhydrous decreases expression EXP 6480464 Cidofovir results in decreased expression of GPNMB mRNA CTD PMID:25596134 cisplatin decreases expression EXP 6480464 Cisplatin results in decreased expression of GPNMB mRNA CTD PMID:25596134 , PMID:27392435 clodronic acid increases expression EXP 6480464 Clodronic Acid results in increased expression of GPNMB mRNA CTD PMID:25596134 cobalt dichloride multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPNMB mRNA CTD PMID:18654764 copper atom multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of GPNMB mRNA CTD PMID:20971185 copper atom increases expression ISO RGD:71008 6480464 Copper results in increased expression of GPNMB mRNA CTD PMID:30556269 copper(0) multiple interactions EXP 6480464 [NSC 689534 binds to Copper] which results in increased expression of GPNMB mRNA CTD PMID:20971185 copper(0) increases expression ISO RGD:71008 6480464 Copper results in increased expression of GPNMB mRNA CTD PMID:30556269 cyclosporin A increases expression ISO RGD:733525 6480464 Cyclosporine results in increased expression of GPNMB mRNA CTD PMID:19770486 cyclosporin A increases expression ISO RGD:71008 6480464 Cyclosporine results in increased expression of GPNMB mRNA CTD PMID:21865292 , PMID:25596134 cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of GPNMB mRNA CTD PMID:20106945 more ... DDT increases methylation ISO RGD:71008 6480464 DDT results in increased methylation of GPNMB gene CTD PMID:30207508 decabromodiphenyl ether increases expression ISO RGD:71008 6480464 decabromobiphenyl ether results in increased expression of GPNMB mRNA CTD PMID:23640034 dexamethasone decreases expression ISO RGD:71008 6480464 Dexamethasone results in decreased expression of GPNMB mRNA CTD PMID:15763343 dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GPNMB mRNA CTD PMID:28628672 dexamethasone multiple interactions ISO RGD:71008 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of GPNMB mRNA] CTD PMID:20032058 dexamethasone increases expression ISO RGD:71008 6480464 Dexamethasone results in increased expression of GPNMB mRNA CTD PMID:20032058 dextran sulfate increases expression ISO RGD:733525 6480464 Dextran Sulfate results in increased expression of GPNMB mRNA CTD PMID:23894361 diarsenic trioxide increases expression EXP 6480464 Arsenic Trioxide results in increased expression of GPNMB mRNA CTD PMID:26705709 , PMID:27829220 dibutyl phthalate increases expression ISO RGD:71008 6480464 Dibutyl Phthalate results in increased expression of GPNMB mRNA CTD PMID:21266533 dichloroacetic acid increases expression ISO RGD:733525 6480464 Dichloroacetic Acid results in increased expression of GPNMB mRNA CTD PMID:28962523 dioxygen increases expression ISO RGD:71008 6480464 Oxygen results in increased expression of GPNMB mRNA, Oxygen results in increased expression of GPNMB protein CTD PMID:22911455 dioxygen multiple interactions ISO RGD:733525 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of GPNMB mRNA CTD PMID:30529165 dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of GPNMB mRNA CTD PMID:25596134 dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of GPNMB mRNA CTD PMID:28940058 , PMID:30031762 doxorubicin decreases expression EXP 6480464 Doxorubicin results in decreased expression of GPNMB mRNA CTD PMID:29803840 endosulfan increases expression ISO RGD:71008 6480464 Endosulfan results in increased expression of GPNMB mRNA CTD PMID:29391264 etoposide increases expression EXP 6480464 Etoposide results in increased expression of GPNMB mRNA CTD PMID:29397400 fenamidone increases expression ISO RGD:733525 6480464 fenamidone results in increased expression of GPNMB mRNA CTD PMID:27029645 flutamide decreases expression ISO RGD:71008 6480464 Flutamide results in decreased expression of GPNMB mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:733525 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPNMB mRNA CTD PMID:20938992 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of GPNMB mRNA CTD PMID:23649840 furan increases expression ISO RGD:71008 6480464 furan results in increased expression of GPNMB mRNA CTD PMID:26194646 gentamycin increases expression ISO RGD:71008 6480464 Gentamicins results in increased expression of GPNMB mRNA CTD PMID:22061828 Hexachloro-1,3-butadiene decreases expression ISO RGD:71008 6480464 hexachlorobutadiene results in decreased expression of GPNMB mRNA CTD PMID:21905055 Hexachloro-1,3-butadiene increases expression ISO RGD:71008 6480464 hexachlorobutadiene results in increased expression of GPNMB mRNA CTD PMID:21905055 indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of GPNMB mRNA CTD PMID:28628672 isoprenaline increases expression ISO RGD:733525 6480464 Isoproterenol results in increased expression of GPNMB mRNA CTD PMID:20003209 L-methionine multiple interactions ISO RGD:733525 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of GPNMB mRNA CTD PMID:20938992 lead(0) affects expression EXP 6480464 Lead affects the expression of GPNMB mRNA CTD PMID:28903495 lead(2+) affects expression EXP 6480464 Lead affects the expression of GPNMB mRNA CTD PMID:28903495 lead(II) chloride multiple interactions EXP 6480464 [cadmium sulfate co-treated with cobaltous chloride co-treated with lead chloride] results in increased expression of GPNMB mRNA CTD PMID:18654764 lipopolysaccharide decreases expression ISO RGD:71008 6480464 Lipopolysaccharides results in decreased expression of GPNMB mRNA CTD PMID:15763343 lucanthone increases expression EXP 6480464 Lucanthone results in increased expression of GPNMB mRNA CTD PMID:21148553 manganese(II) chloride increases expression ISO RGD:71008 6480464 manganese chloride results in increased expression of GPNMB mRNA CTD PMID:28801915 medroxyprogesterone acetate multiple interactions EXP 6480464 [Estradiol co-treated with Bucladesine co-treated with Medroxyprogesterone Acetate] results in decreased expression of GPNMB mRNA CTD PMID:20823114 melamine increases expression ISO RGD:71008 6480464 melamine results in increased expression of GPNMB CTD PMID:23052191 mercury dibromide increases expression EXP 6480464 mercuric bromide results in increased expression of GPNMB mRNA CTD PMID:26272509 mercury dibromide multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPNMB mRNA CTD PMID:27188386 mercury dichloride increases expression ISO RGD:71008 6480464 Mercuric Chloride results in increased expression of GPNMB mRNA CTD PMID:16507785 metformin increases expression ISO RGD:71008 6480464 Metformin results in increased expression of GPNMB mRNA CTD PMID:25596134 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of GPNMB mRNA CTD PMID:25290377 milrinone increases expression ISO RGD:71008 6480464 Milrinone results in increased expression of GPNMB mRNA CTD PMID:22936366 N-methyl-4-phenylpyridinium increases expression ISO RGD:71008 6480464 1-Methyl-4-phenylpyridinium results in increased expression of GPNMB mRNA CTD PMID:16026605 , PMID:28801915 N-nitrosodiethylamine increases expression ISO RGD:71008 6480464 Diethylnitrosamine results in increased expression of GPNMB mRNA CTD PMID:19638242 N-nitrosodiethylamine multiple interactions ISO RGD:71008 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of GPNMB mRNA CTD PMID:28943392 N-nitrosodimethylamine increases expression ISO RGD:71008 6480464 Dimethylnitrosamine results in increased expression of GPNMB mRNA CTD PMID:25380136 nickel atom decreases expression EXP 6480464 Nickel results in decreased expression of GPNMB mRNA CTD PMID:24768652 nickel sulfate increases expression EXP 6480464 nickel sulfate results in increased expression of GPNMB mRNA CTD PMID:16314067 , PMID:22714537 nicotine increases expression EXP 6480464 Nicotine results in increased expression of GPNMB mRNA CTD PMID:23825647 nitrofen decreases expression ISO RGD:71008 6480464 nitrofen results in decreased expression of GPNMB mRNA CTD PMID:26720608 oxaliplatin multiple interactions ISO RGD:71008 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GPNMB mRNA CTD PMID:25729387 oxaliplatin increases expression ISO RGD:71008 6480464 oxaliplatin results in increased expression of GPNMB mRNA CTD PMID:25729387 p-chloromercuribenzoic acid increases expression EXP 6480464 p-Chloromercuribenzoic Acid results in increased expression of GPNMB mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions EXP 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPNMB mRNA CTD PMID:27188386 paclitaxel increases expression ISO RGD:71008 6480464 Paclitaxel results in increased expression of GPNMB mRNA CTD PMID:18754875 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of GPNMB mRNA CTD PMID:26690555 paracetamol increases expression ISO RGD:733525 6480464 Acetaminophen results in increased expression of GPNMB mRNA CTD PMID:24126418 phenacetin increases expression ISO RGD:71008 6480464 Phenacetin results in increased expression of GPNMB mRNA CTD PMID:17082564 , PMID:17698508 phenylhydrazine increases expression ISO RGD:71008 6480464 phenylhydrazine results in increased expression of GPNMB mRNA CTD PMID:17082564 , PMID:17698508 phenylmercury acetate increases expression EXP 6480464 Phenylmercuric Acetate results in increased expression of GPNMB mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions EXP 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of GPNMB mRNA CTD PMID:27188386 quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of GPNMB mRNA CTD PMID:21632981 raloxifene multiple interactions EXP 6480464 Raloxifene Hydrochloride inhibits the reaction [Estradiol results in decreased expression of GPNMB mRNA] CTD PMID:21185374 resorcinol increases expression EXP 6480464 resorcinol results in increased expression of GPNMB mRNA CTD PMID:22623647 rotenone increases expression ISO RGD:71008 6480464 Rotenone results in increased expression of GPNMB mRNA CTD PMID:28374803 Salinomycin decreases expression EXP 6480464 salinomycin results in decreased expression of GPNMB mRNA CTD PMID:19682730 SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide decreases expression EXP 6480464 Silicon Dioxide analog results in decreased expression of GPNMB mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:733525 6480464 Silicon Dioxide results in increased expression of GPNMB mRNA CTD PMID:26345256 , PMID:29203145 silicon dioxide increases expression ISO RGD:71008 6480464 Silicon Dioxide results in increased expression of GPNMB mRNA CTD PMID:18685790 , PMID:22431001 sirolimus increases expression ISO RGD:71008 6480464 Sirolimus results in increased expression of GPNMB mRNA CTD PMID:21865292 sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of GPNMB mRNA, sodium arsenite results in increased expression of GPNMB mRNA alternative form CTD PMID:21281968 more ... sodium dichromate increases expression ISO RGD:71008 6480464 sodium bichromate results in increased expression of GPNMB mRNA CTD PMID:25993096 tacrolimus hydrate increases expression ISO RGD:71008 6480464 Tacrolimus results in increased expression of GPNMB mRNA CTD PMID:21865292 tamoxifen affects expression ISO RGD:733525 6480464 Tamoxifen affects the expression of GPNMB mRNA CTD PMID:17555576 tert-butyl hydroperoxide decreases expression EXP 6480464 tert-Butylhydroperoxide results in decreased expression of GPNMB mRNA CTD PMID:15336504 testosterone multiple interactions ISO RGD:71008 6480464 Testosterone inhibits the reaction [Dexamethasone results in increased expression of GPNMB mRNA] CTD PMID:20032058 tetrachloroethene increases expression ISO RGD:733525 6480464 Tetrachloroethylene results in increased expression of GPNMB mRNA CTD PMID:28973375 tetrachloromethane increases expression ISO RGD:71008 6480464 Carbon Tetrachloride results in increased expression of GPNMB mRNA CTD PMID:15763343 tetrachloromethane multiple interactions ISO RGD:733525 6480464 PANX1 protein affects the reaction [Carbon Tetrachloride results in increased expression of GPNMB mRNA] CTD PMID:29987408 tetrachloromethane increases expression ISO RGD:733525 6480464 Carbon Tetrachloride results in increased expression of GPNMB mRNA CTD PMID:27339419 , PMID:29987408 tetrachloromethane affects expression ISO RGD:733525 6480464 Carbon Tetrachloride affects the expression of GPNMB mRNA CTD PMID:17484886 thioacetamide increases expression ISO RGD:71008 6480464 Thioacetamide results in increased expression of GPNMB mRNA CTD PMID:23411599 thioacetamide multiple interactions ISO RGD:71008 6480464 [Diethylnitrosamine co-treated with Thioacetamide] results in increased expression of GPNMB mRNA CTD PMID:28943392 titanium dioxide increases expression ISO RGD:733525 6480464 titanium dioxide results in increased expression of GPNMB mRNA CTD PMID:19464567 more ... topotecan increases expression ISO RGD:71008 6480464 Topotecan results in increased expression of GPNMB mRNA CTD PMID:25729387 topotecan multiple interactions ISO RGD:71008 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of GPNMB mRNA CTD PMID:25729387 trichloroethene decreases expression ISO RGD:71008 6480464 Trichloroethylene results in decreased expression of GPNMB mRNA CTD PMID:17905399 trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of GPNMB mRNA CTD PMID:24935251 triclosan increases expression EXP 6480464 Triclosan results in increased expression of GPNMB mRNA CTD PMID:30510588 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of GPNMB mRNA CTD PMID:19140230 troglitazone increases expression ISO RGD:71008 6480464 troglitazone results in increased expression of GPNMB mRNA CTD PMID:25596134 urethane decreases expression EXP 6480464 Urethane results in decreased expression of GPNMB mRNA CTD PMID:28818685 ursodeoxycholic acid decreases expression ISO RGD:71008 6480464 Ursodeoxycholic Acid results in decreased expression of GPNMB mRNA CTD PMID:15885361 valproic acid decreases expression EXP 6480464 Valproic Acid results in decreased expression of GPNMB mRNA CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of GPNMB mRNA CTD PMID:23179753 more ... vinclozolin affects expression ISO RGD:71008 6480464 vinclozolin affects the expression of GPNMB mRNA CTD PMID:19015723 vinclozolin increases expression ISO RGD:71008 6480464 vinclozolin results in increased expression of GPNMB mRNA CTD PMID:23034163 vincristine increases expression EXP 6480464 Vincristine results in increased expression of GPNMB mRNA CTD PMID:23649840 zoledronic acid decreases expression EXP 6480464 zoledronic acid results in decreased expression of GPNMB mRNA CTD PMID:24714768
Gene-Chemical Interaction Annotations
